GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xylo Technologies Ltd (NAS:XYLO) » Definitions » Total Liabilities

Xylo Technologies (Xylo Technologies) Total Liabilities : $31.46 Mil (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Xylo Technologies Total Liabilities?

Xylo Technologies's Total Liabilities for the quarter that ended in Dec. 2023 was $31.46 Mil.

Xylo Technologies's quarterly Total Liabilities declined from Dec. 2022 ($42.96 Mil) to Jun. 2023 ($41.22 Mil) and declined from Jun. 2023 ($41.22 Mil) to Dec. 2023 ($31.46 Mil).

Xylo Technologies's annual Total Liabilities increased from Dec. 2021 ($8.30 Mil) to Dec. 2022 ($42.96 Mil) but then declined from Dec. 2022 ($42.96 Mil) to Dec. 2023 ($31.46 Mil).


Xylo Technologies Total Liabilities Historical Data

The historical data trend for Xylo Technologies's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xylo Technologies Total Liabilities Chart

Xylo Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.20 6.14 8.30 42.96 31.46

Xylo Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.30 41.13 42.96 41.22 31.46

Xylo Technologies Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Xylo Technologies's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=29.268+(0.702+-2.1961599205866E-15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+1.465+0.026)
=31.46

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=63.896-32.435
=31.46

Xylo Technologies's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=29.268+(0.702+-2.1961599205866E-15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+1.465+0.026)
=31.46

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=63.896-32.435
=31.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Xylo Technologies Total Liabilities Related Terms

Thank you for viewing the detailed overview of Xylo Technologies's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Xylo Technologies (Xylo Technologies) Business Description

Traded in Other Exchanges
Address
10 Hanechoshet Street, 4th Floor, Tel Aviv, ISR, 6971072
Medigus Ltd is an Israel-based medical device company. It is engaged in the development, manufacturing, and marketing of surgical endostaplers and direct vision systems for minimally invasive medical procedures. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incisionless treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company also develops a range of micro video cameras under the micro ScoutCam portfolio of products. It operates in five segments: Medical, E-Commerce, Online, Electric Vehicles, and Corporate. The company's geographical segments include the United States, United Kingdom, Germany, Israel, China, and Others.

Xylo Technologies (Xylo Technologies) Headlines